David Hollander - 29 Sep 2023 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Director
Signature
/s/ Melissa Tosca, Attorney-in-Fact
Issuer symbol
KPRX
Transactions as of
29 Sep 2023
Transactions value $
$0
Form type
4
Filing time
03 Oct 2023, 16:44:38 UTC
Previous filing
07 Mar 2023
Next filing
29 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPRX Stock Option (right to buy) Award $0 0 0% $0* 5,000 29 Sep 2023 Common Stock 5,000 $0.5677 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024.